Research reports increase in psychological distress in the UK during first COVID-19 wave

New research published in Economic Inquiry reports substantial increases in psychological distress in the UK during the first wave of the COVID-19 pandemic.

Mental health effects were more pronounced for females; younger individuals; Black, Asian, and minority ethnic communities; and migrants. Also, people who had financial worries, loneliness, or were living in overcrowded dwellings experienced significantly worse mental health deterioration during the first wave.

The study used data from the UKHLS, also known as Understanding Society, which is a household panel dataset that captures, among other things, information from adults about their economic and social circumstances, lifestyle, employment, family relationships, and mental health.

We found that the average mental health deterioration from the first wave was significantly larger than that associated with some distressing events such as divorce and widowhood, and it was also a sizable fraction of the mental fallout associated with unemployment. We also found significant variation in impacts across people with different life circumstances. We hope these findings will help inform policy responses to future pandemics whose recurrence cannot be ruled out, sadly."

Gaston Yalonetzky, PhD, corresponding author, Leeds University Business School, UK

Source:
Journal reference:

Anaya, L., et al. (2023) Locked down in distress: a quasi-experimental estimation of the mental-health fallout from the COVID-19 pandemic. Economic Inquiry. doi.org/10.1111/ecin.13181.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients